The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
Open accessAbstract
We have devised and tested a new strategy for selectively delivering molecules to tumor cells. Cellular association of polyarginine-based, cell-penetrating peptides (CPPs) is effectively blocked when they are fused to an inhibitory domain made up of negatively charged residues. We call these fusions activatable CPPs (ACPPs) because cleavage of the linker between the polycationic and polyanionic domains, typically by a protease, releases the CPP portion and its attached cargo to bind to and enter cells. Association with cultured cells typically increases 10-fold or more upon linker cleavage. In mice xenografted with human tumor cells secreting matrix metalloproteinases 2 and 9, ACPPs bearing a far-red-fluorescent cargo show in vivo contrast ratios of 2-3 and a 3.1-fold increase in standard uptake value for tumors relative to contralateral normal tissue or control peptides with scrambled linkers. Ex vivo slices of freshly resected human squamous cell carcinomas give similar or better contrast ratios. Because CPPs are known to import a wide variety of nonoptical contrast and therapeutic agents, ACPPs offer a general strategy toward imaging and treating disease processes associated with linker-cleaving activities such as extracellular proteases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Vivès, E., Brodin, P., & Lebleu, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.16010 · Cited by 2,373
Lewin, M., Carlesso, N., Tung, C.-H., Tang, X.-W., Cory, D., Scadden, D. T., & Weissleder, R. (2000) · Nature Biotechnology · doi:10.1038/74464 · Cited by 1,716
Wadia, J. S., Stan, R. V., & Dowdy, S. F. (2004) · Nature Medicine · doi:10.1038/nm996 · Cited by 1,647
Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., & Rothbard, J. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13003 · Cited by 1,615
Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., & Lebleu, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209548200 · Cited by 1,446
Weissleder, R., & Mahmood, U. (2001) · Radiology · doi:10.1148/radiology.219.2.r01ma19316 · Cited by 1,315
Etzioni, R., Urban, N., Ramsey, S., McIntosh, M., Schwartz, S., Reid, B., Radich, J., Anderson, G., & Hartwell, L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1041 · Cited by 1,155
Fluorescence molecular tomography resolves protease activity in vivo
Ntziachristos, V., Tung, C.-H., Bremer, C., & Weissleder, R. (2002) · Nature Medicine · doi:10.1038/nm729 · Cited by 827
Yamaoka, T., Tabata, Y., & Ikada, Y. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830432 · Cited by 748
In vivo molecular target assessment of matrix metalloproteinase inhibition
Bremer, C., Tung, C.-H., & Weissleder, R. (2001) · Nature Medicine · doi:10.1038/89126 · Cited by 726
Matrix Metalloproteinases: Regulation and Dysregulation in the Failing Heart
Spinale, F. G. (2002) · Circulation Research · doi:10.1161/01.res.0000013290.12884.a3 · Cited by 726
von Lampe, B., Barthel, B., Coupland, S. E., Riecken, E.-O., & Rosewicz, S. (2000) · Gut · doi:10.1136/gut.47.1.63 · Cited by 386
Arginine-Rich Molecular Transporters for Drug Delivery: Role of Backbone Spacing in Cellular Uptake
Rothbard, J. B., Kreider, E., VanDeusen, C. L., Wright, L., Wylie, B. L., & Wender, P. A. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0105676 · Cited by 328
Monoclonal antibodies as therapeutic agents for cancer
Harris, M. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01467-6 · Cited by 320
Zhao, M., Kircher, M. F., Josephson, L., & Weissleder, R. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0255236 · Cited by 319
Uptake of analogs of penetratin, Tat(48–60) and oligoarginine in live cells
Thorén, P. E. G., Persson, D., Isakson, P., Goksör, M., Önfelt, A., & Nordén, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01135-5 · Cited by 303
Cell surface adherence and endocytosis of protein transduction domains
Lundberg, M., Wikström, S., & Johansson, M. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00135-7 · Cited by 301
Optical Imaging of Matrix Metalloproteinase–2 Activity in Tumors: Feasibility Study in a Mouse Model
Bremer, C., Bredow, S., Mahmood, U., Weissleder, R., & Tung, C.-H. (2001) · Radiology · doi:10.1148/radiol.2212010368 · Cited by 255
Potocky, T. B., Menon, A. K., & Gellman, S. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308719200 · Cited by 237
Sundaresan, G., Yazaki, P. J., Shively, J. E., Finn, R. D., Larson, S. M., Raubitschek, A. A., Williams, L. E., Chatziioannou, A. F., Gambhir, S. S., & Wu, A. M. (2003) · PubMed · Cited by 222
Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
Talvensaari-Mattila, A., Pääkkö, P., & Turpeenniemi-Hujanen, T. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601238 · Cited by 217
Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera
Rocca, G. L., Pucci-Minafra, I., Marrazzo, A., Taormina, P., & Minafra, S. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601725 · Cited by 197
An Operational Near-Infrared Fluorescence Imaging System Prototype for Large Animal Surgery
De Grand, A. M., & Frangioni, J. V. (2003) · Technology in Cancer Research & Treatment · doi:10.1177/153303460300200607 · Cited by 189
Protease sensors for bioimaging
Funovics, M., Weissleder, R., & Tung, C.-H. (2003) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-003-2199-0 · Cited by 186
Cancer : a problem of developmental biology
Pierce, G. B., Shikes, R. H., & Fink, L. M. (1978) · Andalas University Repository (Andalas University) · Cited by 166
Bhorade, R., Weissleder, R., Nakakoshi, T., Moore, A., & Tung, C.-H. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990168d · Cited by 163
Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis
Sounni, N. E., Janssen, M., Foidart, J., & Noël, A. (2003) · Matrix Biology · doi:10.1016/s0945-053x(03)00003-9 · Cited by 119
Matrix metalloproteinase inhibitors in rheumatic diseases
Close, D. R. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.90003.iii62 · Cited by 104
Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease
Leake, A., Morris, C. M., & Whateley, J. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01418-x · Cited by 95
Olafsen, T., Tan, G., Cheung, C. W., Yazaki, P. J., Park, J. M., Shively, J. E., Williams, L. E., Raubitschek, A. A., Press, M. F., & Wu, A. M. (2004) · Protein Engineering Design and Selection · doi:10.1093/protein/gzh040 · Cited by 88
The ADAMs family of proteins: from basic studies to potential clinical applications
Lynn, D. J., Lloyd, A. T., O'Shea, C., & Duffy, M. J. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613568 · Cited by 75
Gammon, S. T., Villalobos, V. M., Prior, J. L., Sharma, V., & Piwnica-Worms, D. R. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0256291 · Cited by 66
Ratnikov, B. I., Deryugina, E. I., & Strongin, A. Y. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000038555.67772.db · Cited by 45
Franc, B. L., Mandl, S. J., Siprashvili, Z., Wender, P. A., & Contag, C. H. (2003) · Molecular Imaging · doi:10.1162/15353500200303148 · Cited by 15
Gagescu, R. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056546 · Cited by 8
Cited by
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
“…pep- tides, which are activated by proteolysis and carry a fluorescent cargo that accumulates in cells that are in the vicinity of active MMPs (Jiang et al., 2004), have been used successfully to visualize MMP-2 and -9 activity in cell culture systems and in mouse xenograft models and show…”
MethodThe Fluorescent Toolbox for Assessing Protein Location and Function
Giepmans, B. N. G., Adams, S. R., Ellisman, M. H., & Tsien, R. Y. (2006) · Science · doi:10.1126/science.1124618 · Cited by 2,770
Self-citationNew Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
Kobayashi, H., Ogawa, M., Alford, R., Choyke, P. L., & Urano, Y. (2010) · Chemical Reviews · doi:10.1021/cr900263j · Cited by 2,200
Tumor metastasis: mechanistic insights and clinical challenges
Steeg, P. S. (2006) · Nature Medicine · doi:10.1038/nm1469 · Cited by 2,134
Cox, T. R., & Erler, J. T. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.004077 · Cited by 1,569
Metadata
- Authors
- Jiang, T., Olson, E. S., Nguyen, Q. T., Roy, M., Jennings, P. A., & Tsien, R. Y.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-12-15
- Volume
- 101
- Issue
- 51
- Pages
- 17867-17872
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2099132605
- Cited by
- 822
- References
- 37
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.